Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Jan 1;99(1):9–13. doi: 10.1172/JCI119138

Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea.

P J Wills 1, R L Hall 1, W Chan 1, P J Cole 1
PMCID: PMC507760  PMID: 9011581

Abstract

Mucus retention in the lungs is an important feature of several respiratory diseases (Regnis, J.A., M. Robinson, D.L. Bailey, P. Cook, P. Hooper, H.K. Chan, I. Gonda, G. Bautovich, and P.T.P. Bye. 1994. Am. J. Respir. Crit. Care Med. 150:66-71 and Currie, D.C., D. Pavia, J.E. Agnew, M.T. Lopez-Vidriero, P.D. Diamond, P.J. Cole, and S.W. Clarke. 1987. Thorax. 42:126-130). On the mucus-depleted bovine trachea, the ciliary transport rate of sputum from patients with cystic fibrosis and bronchiectasis of other causes was slow, but the rate was doubled by increasing the sodium chloride content by 90 mM. Increasing the sputum osmolality by inspissation or by the addition of nonelectrolytes had a similar effect. The viscoelasticity of sputum, but not the bovine ciliary beat frequency, was markedly saline dependent over the pathophysiological range. This suggests that low mucus salinity, not (as is generally assumed) its under-hydration, contributes to its retention in bronchiectasis due to cystic fibrosis and other causes, probably by affecting its theology. It also indicates how the genetic defect in cystic fibrosis might lead to impaired mucus clearance. Therapies that increase the osmolality of lung mucus might benefit patients with mucus retention.

Full Text

The Full Text of this article is available as a PDF (164.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. App E. M., King M., Helfesrieder R., Köhler D., Matthys H. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy. Am Rev Respir Dis. 1990 Mar;141(3):605–612. doi: 10.1164/ajrccm/141.3.605. [DOI] [PubMed] [Google Scholar]
  2. Bennett W. D., Olivier K. N., Zeman K. L., Hohneker K. W., Boucher R. C., Knowles M. R. Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1796–1801. doi: 10.1164/ajrccm.153.6.8665037. [DOI] [PubMed] [Google Scholar]
  3. Boucher R. C. Human airway ion transport. Part two. Am J Respir Crit Care Med. 1994 Aug;150(2):581–593. doi: 10.1164/ajrccm.150.2.8049852. [DOI] [PubMed] [Google Scholar]
  4. Boucher R. C., Stutts M. J., Knowles M. R., Cantley L., Gatzy J. T. Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J Clin Invest. 1986 Nov;78(5):1245–1252. doi: 10.1172/JCI112708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Daviskas E., Anderson S. D., Gonda I., Eberl S., Meikle S., Seale J. P., Bautovich G. Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. Eur Respir J. 1996 Apr;9(4):725–732. doi: 10.1183/09031936.96.09040725. [DOI] [PubMed] [Google Scholar]
  6. Eng P. A., Morton J., Douglass J. A., Riedler J., Wilson J., Robertson C. F. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol. 1996 Feb;21(2):77–83. doi: 10.1002/(SICI)1099-0496(199602)21:2<77::AID-PPUL3>3.0.CO;2-M. [DOI] [PubMed] [Google Scholar]
  7. Girod S., Zahm J. M., Plotkowski C., Beck G., Puchelle E. Role of the physiochemical properties of mucus in the protection of the respiratory epithelium. Eur Respir J. 1992 Apr;5(4):477–487. [PubMed] [Google Scholar]
  8. Graham A., Hasani A., Alton E. W., Martin G. P., Marriott C., Hodson M. E., Clarke S. W., Geddes D. M. No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur Respir J. 1993 Oct;6(9):1243–1248. [PubMed] [Google Scholar]
  9. Harding S. E., Creeth J. M. Polyelectrolyte behaviour in mucus glycoproteins. Biochim Biophys Acta. 1983 Jul 28;746(1-2):114–119. doi: 10.1016/0167-4838(83)90017-1. [DOI] [PubMed] [Google Scholar]
  10. Joris L., Dab I., Quinton P. M. Elemental composition of human airway surface fluid in healthy and diseased airways. Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1633–1637. doi: 10.1164/ajrccm/148.6_Pt_1.1633. [DOI] [PubMed] [Google Scholar]
  11. Knowles M. R., Church N. L., Waltner W. E., Yankaskas J. R., Gilligan P., King M., Edwards L. J., Helms R. W., Boucher R. C. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med. 1990 Apr 26;322(17):1189–1194. doi: 10.1056/NEJM199004263221704. [DOI] [PubMed] [Google Scholar]
  12. Kollberg H., Mossberg B., Afzelius B. A., Philipson K., Camner P. Cystic fibrosis compared with the immotile-cilia syndrome. A study of mucociliary clearance, ciliary ultrastructure, clinical picture and ventilatory function. Scand J Respir Dis. 1978;59(6):297–306. [PubMed] [Google Scholar]
  13. Luk C. K., Dulfano M. J. Effect of pH, viscosity and ionic-strength changes on ciliary beating frequency of human bronchial explants. Clin Sci (Lond) 1983 Apr;64(4):449–451. doi: 10.1042/cs0640449. [DOI] [PubMed] [Google Scholar]
  14. MATTHEWS L. W., SPECTOR S., LEMM J., POTTER J. L. STUDIES ON PULMONARY SECRETIONS. I. THE OVER-ALL CHEMICAL COMPOSITION OF PULMONARY SECRETIONS FROM PATIENTS WITH CYSTIC FIBROSIS, BRONCHIECTASIS, AND LARYNGECTOMY. Am Rev Respir Dis. 1963 Aug;88:199–204. doi: 10.1164/arrd.1963.88.2.199. [DOI] [PubMed] [Google Scholar]
  15. Mizgerd J. P., Kobzik L., Warner A. E., Brain J. D. Effects of sodium concentration on human neutrophil bactericidal functions. Am J Physiol. 1995 Sep;269(3 Pt 1):L388–L393. doi: 10.1152/ajplung.1995.269.3.L388. [DOI] [PubMed] [Google Scholar]
  16. Pavia D., Thomson M. L., Clarke S. W. Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am Rev Respir Dis. 1978 Feb;117(2):199–203. doi: 10.1164/arrd.1978.117.2.199. [DOI] [PubMed] [Google Scholar]
  17. Potter J. L., Matthews L. W., Spector S., Lemm J. Studies on pulmonary secretions. II. Osmolality and the ionic environment of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am Rev Respir Dis. 1967 Jul;96(1):83–87. doi: 10.1164/arrd.1967.96.1.83. [DOI] [PubMed] [Google Scholar]
  18. Quinton P. M. Viscosity versus composition in airway pathology. Am J Respir Crit Care Med. 1994 Jan;149(1):6–7. doi: 10.1164/ajrccm.149.1.8111599. [DOI] [PubMed] [Google Scholar]
  19. Robinson M., Regnis J. A., Bailey D. L., King M., Bautovich G. J., Bye P. T. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med. 1996 May;153(5):1503–1509. doi: 10.1164/ajrccm.153.5.8630593. [DOI] [PubMed] [Google Scholar]
  20. Rutland J., Cole P. J. Non-invasive sampling of nasal cilia for measurement of beat frequency and study of ultrastructure. Lancet. 1980 Sep 13;2(8194):564–565. doi: 10.1016/s0140-6736(80)91995-9. [DOI] [PubMed] [Google Scholar]
  21. Smith J. J., Travis S. M., Greenberg E. P., Welsh M. J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 1996 Apr 19;85(2):229–236. doi: 10.1016/s0092-8674(00)81099-5. [DOI] [PubMed] [Google Scholar]
  22. Tomkiewicz R. P., App E. M., Zayas J. G., Ramirez O., Church N., Boucher R. C., Knowles M. R., King M. Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):1002–1007. doi: 10.1164/ajrccm/148.4_Pt_1.1002. [DOI] [PubMed] [Google Scholar]
  23. Wills P. J., Garcia Suarez M. J., Rutman A., Wilson R., Cole P. J. The ciliary transportability of sputum is slow on the mucus-depleted bovine trachea. Am J Respir Crit Care Med. 1995 Apr;151(4):1255–1258. doi: 10.1164/ajrccm.151.4.7697262. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES